MedTrace Logo

Evaluation of ONYX in ENDOVASCULAR Treatment of Cerebral AVMs

NCT02180958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2022-01-31

No results posted yet for this study

Summary

To assess safety and efficacy of ONYX treatment for cAVM:

Conditions

  • Cerebral Arteriovenous Malformations

Sponsors & Collaborators

  • Medtronic Neurovascular Clinical Affairs

    lead INDUSTRY

Principal Investigators

  • Frédéric Ricolfi, Prof. Dr. · Centre Hospitalier Universitaire Dijon

  • Christophe Cognard, Prof. Dr. · University Hospital, Toulouse

  • Laurent Spelle, Prof. Dr. · Hôpital Bicêtre

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02180958 on ClinicalTrials.gov